一度火热的肿瘤免疫治疗受“魏则西事件”的影响被迅速降温。针对这一状况，笔者客观介绍肿瘤免疫治疗的发展历程、发展趋势及优缺点，并从癌症患者、监管部门、医疗机构及业内专家等多个角度解析当前肿瘤免疫治疗存在的问题及可能的对策，以期为建立适合我国国情的肿瘤免疫治疗发展路径提供参考意见。

Cancer immunotherapy, once one of hottest area in China, has been rapidly cooled-down or even frozen by the “Event of Wei Zexi” nowadays. In view of the situation, we objectively introduced development history and future trends of cancer immunotherapy, and its advantages and disadvantages. Current problems of cancer immunotherapy and their possible countermeasures were analyzed from multiple perspectives including the patients with tumor, regulatory authorities, medical institutions and experts of the industry. It could provide constructive opinions for establishment of cancer immunotherapy development path which is suitable for national conditions of China.

国家科技重大专项资助项目（No. 2013ZX10002-010-007））和上海市科学技术委员会工程中心能力提升项目（No.16DZ2281000）